Cell cycle arrest and anti-cancer potential of probiotic Lactobacillus rhamnosus against HT-29 cancer cells

Najme Dehghani ¹ , Farzaneh Tafvizi ¹ * , Parvaneh Jafari ²

Cited by CrossRef: 3

1- Doublier S, Cirrincione S, Scardaci R, Botta C, Lamberti C, Giuseppe F, Angelucci S, Rantsiou K, Cocolin L, Pessione E. Putative probiotics decrease cell viability and enhance chemotherapy effectiveness in human cancer cells: role of butyrate and secreted proteins. Microbiological Research. 2022;260:127012 [Crossref]

2- Arun K, Sindhu R, Alex D, Binod P, Pughazhendi A, Joseph T, Pandey A, Kuddus M, Pillai S, Emmanual S, Awasthi M, Madhavan A. Bacterial bioactive metabolites as therapeutic agents: From production to action. Sustainable Chemistry and Pharmacy. 2022;27:100650 [Crossref]

3- Nowak A, Zakłos-Szyda M, Rosicka-Kaczmarek J, Motyl I. Anticancer Potential of Post-Fermentation Media and Cell Extracts of Probiotic Strains: An In Vitro Study. Cancers. 2022;14(7):1853 [Crossref]

4- Di Luccia B, Acampora V, Saggese A, Calabrò V, Vivo M, Angrisano T, Baccigalupi L, Ricca E, Pollice A. Modulation of intestinal epithelial cell proliferation and apoptosis by Lactobacillus gasseri SF1183. Sci Rep. 2022;12(1) [Crossref]

5- Ryu S, Kim J, Oh B, Choi W, Yu S, Bak J, Park S, Kang S, Lee J, Jung W, Lee J, Lee J, Xu Z. Gut Microbiota Eubacterium callanderi Exerts Anti-Colorectal Cancer Activity. Microbiol Spectr. 2022; [Crossref]

6- Han M, Wang N, Han W, Ban M, Sun T, Xu J. Gut Microbes in Gynecologic Cancers: Causes or Biomarkers and Therapeutic Potential. Front Oncol. 2022;12 [Crossref]

7- Dolati M, Tafvizi F, Salehipour M, Komeili Movahed T, Jafari P. Antiproliferative Potential of Bacillus coagulans Supernatant on SKBR3 Breast Cancer Cell Line. Iran J Med Microbiol. 2022;16(5):383 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences and provides free editing services.
Acceptance rate: 24%
First decision: 2-3 days
Final decision: 3-6 weeks
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; Web of Science; SJR ; Essential Science Indicators; Publons; Indexcopernicus; Embase; EBSCOhost; CAS: DOAJ: JournalSeek; ResearchBib; SHERPA/RoMEO; Ulrich; MIAR
Member of COPE
Follower of ICMJE
Permission: Creative Commons